Contraception
Japan-based Sosei Group initiates phase 1 trial for emergency contraceptive pill NorLevo
Published in Women's Health Weekly, December 21st, 2006
Sosei acquired the exclusive distribution rights to the product in Japan from Laboratoire HRA Pharma; it is currently approved and marketed in over 50 countries.
The clinical study is a randomized, double blind, placebo-controlled trial designed to evaluate the safety and pharmacokinetics of SOH-075 in healthy Japanese adult female volunteers. A total of 33 volunteers in three cohorts will be enrolled at a single study center.
NorLevo is an oral...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
Hypnosis helps women cope with breast biopsy - Contraception
Studies show permanent birth control procedure is option when tubal ligation unsuitable - Menorrhagia
Eight studies evaluating Cytyc's NovaSure System for endometrial ablation presented - Osteoporosis
Study comparing two osteoporosis drugs in 33,830 women shows difference in hip fracture rate - Breast Cancer
Data from University of Virginia, Department of Surgery advance knowledge in breast cancer - Breast Cancer
Findings from Brigham and Women's Hospital provide new insights into breast cancer - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
